Pharmacopeia
Master Compare
Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.
| Field |
BENZYL PENICILLIN
Anti-infectives · Anti-infectives · Level 1
|
METRONIDAZOLE
Anti-infectives · Anti-infectives · Level 3
|
|---|---|---|
| Mechanism of action | β lactam antibiotic |
Converted to active form or nitroso free radical by |
| Absorption | Orally not absorbed (need penicillin V) |
50% PO BA |
| Distribution | CSF and bone penetration if inflammation present |
Widely distributed to all tissues |
| Protein binding | 60% PB |
10% PB |
| Volume of distribution | Vd <1L/kg |
Vd 0.75 L/kg |
| Metabolism | Inactive metabolite penicollic acid |
Hepatic Oxidation and glucuronidation |
| Excretion | 90% excreted in urine by tubular secretion |
Renal excretion 60% unchanged |
| Half-life | — | T1/2 = 6-10hrs |
| Adverse Effects Toxicity | GIT– abdominal pain, N/V/D, pseudomembranous colitis, hepatitis |
GIT– abdominal pain, N/V/D, |
| Antimicrobial Spectrum | Narrow-Spectrum Highly bactericidal, only Targets Synergistic effects with |
Active against anaerobes (including clostridium, N.Gonorrhoea, N.Menigitidis, Bacterioides and Fusobacterium) and protozoa |
| Class Group | ANTIBIOTIC: |
ANTIBIOTIC: |
| Introduction | Narrow spectrum naturally occurring penicillin |
Nitroimidazole |
| Legacy Cicm Level | Level 1 |
Level 3 |
| Resistance Mechanism | Resistance |
reduced rate of uptake, by efflux or by reducing the rate of metronidazole reductive activation |